Background Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent
nuclear transcription factors that regulate β-oxidation of fatty acids in various tissues. PPARα …

Peroxisome proliferator-activated receptor-γ (PPARγ) ligands are widely used in patients
with insulin resistance and diabetes. Because coronary artery disease is a major …

Peroxisome proliferator-acitivated receptor α (PPARα) is a member of nuclear receptor
superfamily. Recent studies have shown that the activators for PPARα inhibit the expression …

Peroxisome proliferator activated receptors (PPARs) are a family of nuclear receptors that,
upon activation with selective ligands, work as transcription factors. Recently, these have …

Diabetic endothelial dysfunction is accompanied by increased oxidative stress and
upregulated proinflammatory and inflammatory mediators in the vasculature. Activation of …

Peroxisome proliferator-activated receptor (PPAR) γ ligands oppose the effect induced by
angiotensin II (Ang II) to reduce oxidative stress and improve antioxidant status. In this study …

Background: The aim of the present study was to examine the chronic effects of α-lipoic acid
on proliferator peroxisome activated receptors-γ (PPAR-γ) and PPAR-α expressions in …

We examined the effects of a variety of ligands/activators of the peroxisome proliferator-
activated receptor (PPAR) on the expression of the superoxide scavenger enzyme, Cu 2+ …

Docosahexaenoic acid (DHA), a peroxisome proliferator–activated receptor-α (PPARα)
activator, reduces blood pressure (BP) in some hypertensive models by unclear …

Insulin resistance and diabetes mellitus promote the atherosclerotic process, where an
endothelial dysfunction plays a key role. The diabetic milieu elevates the production of the …